24/7 Wellness Updates
Your athletic well-being doesn't keep business hours, and neither do we.
Tune in any time for the most up-to-date wellness info.
The Amylin Opportunity — Why GLP-1s Alone May Not Be Enough
GLP-1s like Ozempic® and Mounjaro® have transformed weight loss—but they may not be enough. Learn why amylin matters and how...
Comparing GLP-1 Options in 2025 — Ozempic, Wegovy, Zepbound, Mounjaro, and Beyond
Which GLP-1 medication is best for weight loss in 2025? We compare Ozempic®, Wegovy®, Zepbound®, Mounjaro®, CagriSema, Retatrutide, and more...
The Semaglutide and Tirzepatide Shortage Has Eased—Here’s What Patients and Providers Need to Know
As semaglutide and tirzepatide return to pharmacy shelves, many patients and providers are asking—what now? Here’s a breakdown of current...
Enhancing GLP-1 Therapy Outcomes: The Role of Amylin Analogues and SLM+
Enhance GLP-1 therapy with amylin analogues like pramlintide and SLM+. Discover how to maximize weight loss results with STAAR LABS’...
The Future of Weight Loss: Emerging GLP-1 Therapies and STAAR LABS’ Amylin Research
Explore emerging GLP-1 therapies like amylin analogues and Retatrutide. Learn about STAAR LABS’ research on pramlintide and SLM+ for weight...
Why Liraglutide and Dulaglutide Aren’t Enough: The Search for a Better GLP-1 Solution
Liraglutide and dulaglutide fall short for weight loss compared to tirzepatide. Learn why and explore better GLP-1 solutions in this...
Tirzepatide and Semaglutide Shortages Resolved: What’s Next for Patients and Providers?
Tirzepatide shortage resolved in 2024, semaglutide in 2025. Explore GLP-1 therapy options, pros, and cons for patients and providers in...
HIIT vs. Strength Training: Finding the Right Balance for Peak Performance
HIIT vs. Strength Training: Finding the Right Balance for Peak Performance 💪🔥 Struggling to decide between HIIT (High-Intensity Interval Training)...
Disclaimers
Add a short description for this section
Collapsible row
Collapsible row
Collapsible row
Collapsible row
Collapsible row
References
Add a short description for this section